EPTIS
BAM Logo

Acute Myeloid Leukaemia Gene Panels (Not Accredited) - AML, myeloid

EPTIS factsheet 497464 | Last revision 2018-08-23 | URL: https://www.eptis.bam.de/pts497464 https://www.eptis.bam.de/pts497464

PT provider
PT provider UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping
Based in United Kingdom
Language(s) English
Remarks Please visit our website for further details: www.ukneqasli.co.uk Developmental programme.
Keywords
Product groups Health care / medical devices
Testing fields Biology
Medical analysis
Technical details
Test item Tested property Testing method
Lyophilsed preparations Variant detection via relevant myeloid gene panel Various molecular biology techniques for the analysis of nucleic acids (DNA/RNA), typically NGS (Next Generation Sequencing)/HTS (High Throughput Sequencing) platforms
-
Aims of the PT scheme
Target group of participants Participation open to both UK and international laboratories.
Linked to specific legislation / standards ISO 17043:2010 ISO 13528:2015 ISO 15189:2012
Additional, subsidiary aims validation of testing methods
Number of participants
Accredited or otherwise reviewed by a 3rd party
Operation is commissioned / requested by
Fees and frequency
Participation fee Please contact UKNEQASLI for details
Regularly operated Yes (2 per annum (each send out includes a minimum of 1 sample))
Year of first operation 2016
Contact details of the PT provider
Provider Contact person
UK NEQAS for Leucocyte Immunophenotyping
4th Floor, Pegasus House, 463a Glossop Road
S10 2QD Sheffield
United Kingdom

Phone: +44 (0) 114 2673600
Fax: +44 (0) 114 2673601
Web: http://www.ukneqasli.co.uk http://www.ukneqasli.co.uk
Mr Stuart Scott
Phone: +44 (0) 114 2673600
Fax: +44 (0) 114 2673601
Email: admin@ukneqasli.co.uk admin@ukneqasli.co.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21